Pages that link to "Q41862824"
Jump to navigation
Jump to search
The following pages link to Down syndrome-associated haematopoiesis abnormalities created by chromosome transfer and genome editing technologies (Q41862824):
Displaying 10 items.
- Site-Specific Genome Engineering in Human Pluripotent Stem Cells (Q26747006) (← links)
- A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges (Q26824073) (← links)
- Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus (Q35183911) (← links)
- Moving toward a higher efficiency of microcell-mediated chromosome transfer (Q37028651) (← links)
- Genome editing: a robust technology for human stem cells (Q39239599) (← links)
- CRISPR/Cas9-induced transgene insertion and telomere-associated truncation of a single human chromosome for chromosome engineering in CHO and A9 cells (Q42371790) (← links)
- Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models (Q47309313) (← links)
- Variation in human chromosome 21 ribosomal RNA genes characterized by TAR cloning and long-read sequencing (Q63649588) (← links)
- Loss of Full-Length GATA1 Expression in Megakaryocytes Is a Sensitive and Specific Immunohistochemical Marker for the Diagnosis of Myeloid Proliferative Disorder Related to Down Syndrome (Q87883059) (← links)
- Current advances in microcell-mediated chromosome transfer technology and its applications (Q89858320) (← links)